AbCellera Biologics Inc

ABCL NASDAQ
ABCL
AbCellera Biologics Inc NASDAQ
 
No trades
Kommande intäkter
Utdelning per andel
Börsvärde
Utdelning
P/E-tal
Kommande intäkter
Utdelning per andel
Börsvärde
Utdelning
P/E-tal

ABCL financial statements

AbCellera Biologics Inc Rapporter – inklusive intäkter, kostnader, vinst och förlust

The total revenue of ABCL for the last quarter is 139.33M USD, and it's 2429.61% higher compared to the previous quarter. The net income of Q4 21 is 59.95M USD.

TTM
Bruttovinst
Totala intäkter
Kostnad för sålda varor
Operating expenses (excl. COGS)
Rörelseintäkt
Non-operating income, total
Pretax income
Equity in earnings
Taxes
Non-controlling/minority interest
After tax other income/expense
Net income before discontinued operations
Discontinued operations
Nettoinkomst
Dilution adjustment
Preferred dividends
Diluted net income available to common stockholders
Vinst per aktie (Basic EPS)
Utspädd vinst per aktie (Diluted EPS)
Average basic shares outstanding
Diluted shares outstanding
EBITDA
EBIT
Totala rörelsekostnader